688 related articles for article (PubMed ID: 22213769)
1. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC
Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769
[TBL] [Abstract][Full Text] [Related]
2. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
[TBL] [Abstract][Full Text] [Related]
3. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.
Lyoo IK; Yoon SJ; Musen G; Simonson DC; Weinger K; Bolo N; Ryan CM; Kim JE; Renshaw PF; Jacobson AM
Arch Gen Psychiatry; 2009 Aug; 66(8):878-87. PubMed ID: 19652127
[TBL] [Abstract][Full Text] [Related]
4. Differential levels of prefrontal cortex glutamate+glutamine in adults with antisocial personality disorder and bipolar disorder: A proton magnetic resonance spectroscopy study.
Smaragdi A; Chavez S; Lobaugh NJ; Meyer JH; Kolla NJ
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():250-255. PubMed ID: 30959086
[TBL] [Abstract][Full Text] [Related]
5. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
6. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
[TBL] [Abstract][Full Text] [Related]
7. Reduced
Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
[TBL] [Abstract][Full Text] [Related]
8. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
[TBL] [Abstract][Full Text] [Related]
9. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
[TBL] [Abstract][Full Text] [Related]
10. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.
Bartha R; Williamson PC; Drost DJ; Malla A; Carr TJ; Cortese L; Canaran G; Rylett RJ; Neufeld RW
Arch Gen Psychiatry; 1997 Oct; 54(10):959-65. PubMed ID: 9337777
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
[TBL] [Abstract][Full Text] [Related]
12. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study.
Marsman A; Mandl RC; Klomp DW; Bohlken MM; Boer VO; Andreychenko A; Cahn W; Kahn RS; Luijten PR; Hulshoff Pol HE
Neuroimage Clin; 2014; 6():398-407. PubMed ID: 25379453
[TBL] [Abstract][Full Text] [Related]
13. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
Dubin MJ; Mao X; Banerjee S; Goodman Z; Lapidus KA; Kang G; Liston C; Shungu DC
J Psychiatry Neurosci; 2016 Apr; 41(3):E37-45. PubMed ID: 26900793
[TBL] [Abstract][Full Text] [Related]
14. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
[TBL] [Abstract][Full Text] [Related]
15. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.
Foerster BR; Pomper MG; Callaghan BC; Petrou M; Edden RA; Mohamed MA; Welsh RC; Carlos RC; Barker PB; Feldman EL
JAMA Neurol; 2013 Aug; 70(8):1009-16. PubMed ID: 23797905
[TBL] [Abstract][Full Text] [Related]
16. Combined glutamate and glutamine levels in pain-processing brain regions are associated with individual pain sensitivity.
Zunhammer M; Schweizer LM; Witte V; Harris RE; Bingel U; Schmidt-Wilcke T
Pain; 2016 Oct; 157(10):2248-2256. PubMed ID: 27649042
[TBL] [Abstract][Full Text] [Related]
17. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy.
Ritter C; Buchmann A; Müller ST; Volleberg M; Haynes M; Ghisleni C; Noeske R; Tuura R; Hasler G
JAMA Psychiatry; 2022 Dec; 79(12):1209-1216. PubMed ID: 36260322
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB
Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study of dynamic neurochemical changes in the dorsolateral prefrontal cortex during working memory.
Oh H; Berrington A; Auer DP; Babourina-Brooks B; Faas H; Jung JY
Eur J Neurosci; 2024 Apr; 59(8):2075-2086. PubMed ID: 38409515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
